Mangrove dolabrane-type of diterpenes tagalsins suppresses tumor growthviaROS-mediated apoptosis and ATM/ATR–Chk1/Chk2-regulated cell cycle arrest

    loading  Checking for direct PDF access through Ovid


Natural compounds are an important source for drug development. With an increasing cancer rate worldwide there is an urgent quest for new anti-cancer drugs. In this study, we show that a group of dolabrane-type of diterpenes, collectively named tagalsins, isolated from the Chinese mangrove genusCeriopshas potent cytotoxicity on a panel of hematologic cancer cells. Investigation of the molecular mechanisms by which tagalsins kill malignant cells revealed that it induces a ROS-mediated damage of DNA. This event leads to apoptosis induction and blockage of cell cycle progression at S-G2 phaseviaactivation of the ATM/ATR—Chk1/Chk2 check point pathway. We further show that tagalsins suppress growth of human T-cell leukemia xenograftsin vivo. Tagalsins show only minor toxicity on healthy cells and are well tolerated by mice. Our study shows a therapeutic potential of tagalsins for the treatment of hematologic malignancies and a new source of anticancer drugs.

What's new?

Mangroves of genusCeriops, widespread and highly utilized in China, are of growing interest in anticancer drug development due to their production of potentially cytotoxic diterpenoids and triterpenoids. Here, a group dolabrane-type diterpenes known as tagalsins isolated from the speciesC. tagalare shown to possess potent killing effects on cancer cells of hematologic origin. Cell death was associated with the production of reactive oxygen species and DNA damage.In vivo, tagalsins significantly delayed the development of human T-cell leukemia in a murine xenograft model.

Related Topics

    loading  Loading Related Articles